Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women

Al Altomari, Chairman and CEO of Agile Therapeutics Inc AGRX, was recently interviewed by Benzinga.

Agile Therapeutics says it is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Its products and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.

The company’s flagship product is Twirla® (levonorgestrel and ethinyl estradiol), a non-daily prescription contraceptive utilizing a transdermal system. Twirla is based on proprietary transdermal patch technology, called Skinfusion®, designed to allow drug delivery through the skin. 

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Featured photo by Brittani Burns on Unsplash